Centessa Pharmaceuticals (CNTA) Treasury Shares (2021 - 2026)

Centessa Pharmaceuticals (CNTA) has 6 years of Treasury Shares data on file, last reported at $1.2 million in Q1 2026.

• Quarterly Treasury Shares rose 3222.17% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 3222.17% YoY) and the FY2025 annual result came in at $984059.0, down 34.83% from the prior year.
• Treasury Shares improved to $1.2 million in Q1 2026 per CNTA's latest filing, from $984059.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $2.2 million in Q2 2024 and bottomed at $34746.0 in Q1 2025.
• The 5-year median for Treasury Shares is $686429.5 (2022), against an average of $815729.4.
• The widest annual swing landed in 2025, when Treasury Shares tumbled 86.29%; it then surged 3222.17% in 2026.
• Tracing CNTA's Treasury Shares over 5 years: stood at $1.8 million in 2022, then tumbled by 82.82% to $310052.0 in 2023, then jumped by 387.04% to $1.5 million in 2024, then tumbled by 34.83% to $984059.0 in 2025, then climbed by 17.3% to $1.2 million in 2026.
• Per Business Quant, the three latest CNTA Treasury Shares figures stand at $1.2 million (Q1 2026), $984059.0 (Q4 2025), and $1.1 million (Q2 2025).

Peer Comparison